Group 1 - The closing price of the company on July 24 was 15.54 yuan, an increase of 2.71%, with a rolling PE ratio of 67.79, marking a new low in 255 days, and a total market value of 4.993 billion yuan [1] - The average PE ratio in the medical device industry is 54.56, with a median of 37.54, placing the company at the 92nd position in the industry ranking [1] - As of the first quarter of 2025, 11 institutions held shares in the company, all being funds, with a total holding of 6.3098 million shares valued at 0.09 billion yuan [1] Group 2 - The main business of the company is the research, production, and sales of blood purification equipment and consumables, along with providing chain blood dialysis medical services [2] - The company's key products include blood perfusion machines, continuous blood purification devices, and various types of dialysis machines and consumables [2] - The company achieved a revenue of 189 million yuan in the first quarter of 2025, representing a year-on-year increase of 16.77%, and a net profit of 37.064 million yuan, up 8.10%, with a gross profit margin of 46.72% [2]
山外山收盘上涨2.71%,滚动市盈率67.79倍,总市值49.93亿元